Executive Director Institute of Addiction Medicine
Psychiatry
Dr. Joseph R. Volpicelli, MD
|
|
Give Review
Joseph Volpicelli is an expert in the field of Psychiatry. He went to medical school at Perelman School of Medicine at the University of Pennsylvania. Joseph R. Volpicelli is also a published MD. He has 75 publication published. The most recent publication is: Effects of naltrexone administered repeatedly across 30 or 60 days on ethanol consumption using a limited access procedure in the rat.
Publications
- Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial.
- A nonopioid procedure for outpatient opioid detoxification.
- Alcohol-induced disinhibition expectancies and impaired control as prospective predictors of problem drinking in undergraduates.
- The BRENDA model: integrating psychosocial treatment and pharmacotherapy for the treatment of alcohol use disorders.
- Cocaine dependence severity predicts outcome in outpatient detoxification from cocaine and alcohol.
- A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients.
- Patient attitudes toward treatment predict attendance in clinical pharmacotherapy trials of alcohol and drug treatment.
- Effect of naltrexone on oral consumption of concurrently available ethanol and cocaine in the rat.
- Alcoholism treatment adherence: older age predicts better adherence and drinking outcomes.
- Carbohydrate-deficient transferrin levels reflect heavy drinking in alcohol-dependent women seeking treatment.
- A comparison of the effects of 6-beta naltrexol and naltrexone on the consumption of ethanol or sucrose using a limited-access procedure in rats.
- Cocaine withdrawal severity and urine toxicology results from treatment entry predict outcome in medication trials for cocaine dependence.
- The Drinking-Induced Disinhibition Scale (DIDS): a measure of three types of disinhibiting effects.
- Impaired control and undergraduate problem drinking.
- A placebo-controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial intervention.
- Combined effects of alcohol and hepatitis C: a secondary analysis of alcohol use biomarkers and high-risk behaviors from two medication trials for alcohol dependence.
- Demographic and social adjustment characteristics of patients with comorbid posttraumatic stress disorder and alcohol dependence: potential pitfalls to PTSD treatment.
- Concurrent cocaine withdrawal alters alcohol withdrawal symptoms.
- Alcohol craving predicts drinking during treatment: an analysis of three assessment instruments.
- Naltrexone in the treatment of alcohol dependence.
- Alcohol drinking in rats during and following morphine injections.
- Differential craving between recovering abstinent alcoholic-dependent subjects and therapeutic users of benzodiazepines.
- The bidirectional effects of shock on alcohol preference in rats.
- Circadian rhythmicity and behavioral depression: I. Effects of stress.
- Circadian rhythmicity and behavioral depression: II. Effects of lighting schedules.
- The influence of control over appetitive and aversive events on alcohol preference in rats.
- Comparative effectiveness and costs of inpatient and outpatient detoxification of patients with mild-to-moderate alcohol withdrawal syndrome.
- Screening for problem drinking in college freshmen.
- Uncontrollable events and alcohol drinking.
- Weight gain in postweaned rats as a function of predictable and unpredictable feeding schedules.
- Naltrexone blocks the post-shock increase of ethanol consumption.
- Tumor rejection in rats after inescapable or escapable shock.
- Effects of an appointment reminder call on patient show rates.
- Decrease in alcohol tolerance: clinical significance in alcohol dependence.
- Naltrexone in alcohol dependence.
- Naltrexone in the treatment of alcoholism: predicting response to naltrexone.
- Opiates and alcohol self-administration in animals.
- Effect of naltrexone on alcohol "high" in alcoholics.
- Medical management of alcohol dependence: clinical use and limitations of naltrexone treatment.
- Amantadine in the early treatment of cocaine dependence: a double-blind, placebo-controlled trial.
- Naltrexone in the treatment of alcoholism: a clinical review.
- A risk-benefit assessment of naltrexone in the treatment of alcohol dependence.
- Morphine enhances selection of both sucrose and ethanol in a two-bottle test.
- Naltrexone for alcoholic adolescents.
- Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence.
- Results of two levels of adjunctive treatment used with the nicotine patch.
- Naltrexone biotransformation and incidence of subjective side effects: a preliminary study.
- Naltrexone and alcohol dependence. Role of subject compliance.
- Low dose of morphine and the consumption of a sweetened ethanol solution: differential effects on acquisition and maintenance.
- Combination of the dopaminergic agent, phentermine, and the serotonergic agent, fenfluramine, in the treatment of cocaine dependence.
- A comparison of the effects of the opioid antagonists naltrexone, naltrindole, and beta-funaltrexamine on ethanol consumption in the rat.
- Reliability and validity of the Cocaine Selective Severity Assessment.
- Effects of naltrexone administered repeatedly across 30 or 60 days on ethanol consumption using a limited access procedure in the rat.
- The effects of naltrexone on alcohol and cocaine use in dually addicted patients.
- Open trials as a method of prioritizing medications for inclusion in controlled trials for cocaine dependence.
- Psychometric properties of the Penn Alcohol Craving Scale.
- The NMDA receptor partial agonist, 1-aminocyclopropanecarboxylic acid (ACPC), reduces ethanol consumption in the rat.
- Psychosocially enhanced treatment for cocaine-dependent mothers: evidence of efficacy.
- A detoxification dialogue.
- Improving naltrexone response: an intervention for medical practitioners to enhance medication compliance in alcohol dependent patients.
- The role of uncontrollable trauma in the development of PTSD and alcohol addiction.
- Sertraline treatment for alcohol dependence: interactive effects of medication and alcoholic subtype.
- Gender and psychiatric comorbidity: impact on clinical presentation of alcohol dependence.
- 6-beta-naltrexol reduces alcohol consumption in rats.
- Amantadine in the treatment of cocaine-dependent patients with severe withdrawal symptoms.
- The effect of antagonists selective for mu- and delta-opioid receptor subtypes on alcohol consumption in C57BL/6 mice.
- Cocaine withdrawal symptoms and initial urine toxicology results predict treatment attrition in outpatient cocaine dependence treatment.
- The effect of gamma-vinyl-GABA on the consumption of concurrently available oral cocaine and ethanol in the rat.
- Double-blind clinical trial of sertraline treatment for alcohol dependence.
- Effectiveness of propranolol for cocaine dependence treatment may depend on cocaine withdrawal symptom severity.
- Drinking behavior and motivation for treatment among alcohol-dependent liver transplant candidates.
- Effect of acamprosate and naltrexone, alone or in combination, on ethanol consumption.
- Predicting treatment response to naltrexone: the influence of craving and family history.
- Alcohol abuse and alcoholism: an overview.
Schools
Perelman School of Medicine University of Pennsylvania
Allentown Mc
Hltheast Tch Hp Allentown Hp
University Of Pa Health System
Doctors Specialties
- Psychiatry
Accepted Insurances
Education
-
University of Pennsylvania Health System -
Perelman School of Medicine at the University of Pennsylvania
Helpful Reviews
Similar Doctors
|
|
Dr. Ho-Hyun Park, MD |
|
|
Dr. Nicholas C. Tenaglia, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nicholas C. Tenaglia, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Edward Schacht, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bruce J. Levin, MD
This Doctor is OpenDoctor Recommended.
|